Evidence map›Paper›PMID 40454011›Full record

ArticleACS omega2025

Machine Learning Enabled Multidimensional Data Utilization Through Multi-Resonance Architecture: A Pathway to Enhanced Accuracy in Biosensing.

Majid Aalizadeh, Morteza Azmoudeh Afshar, Xudong Fan

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Majid AalizadehDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan 48109, United States.ORCID https://orcid.org/0000-0002-4312-1940
Morteza Azmoudeh AfsharInformatics Institute, Istanbul Technical University, Istanbul 34485, Turkey.
Xudong FanDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan 48109, United States.ORCID https://orcid.org/0000-0003-0149-1326

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel framework is proposed that combines multiresonance biosensors with machine learning (ML) to significantly enhance the accuracy of parameter prediction in biosensing. Unlike traditional single-resonance systems, which are limited to one-dimensional data sets, this approach leverages multidimensional data generated by a custom-designed nanostructurea periodic array of silicon nanorods with a triangular cross section over an aluminum reflector. High bulk sensitivity values are achieved for this multiresonant structure, with certain resonant peaks reaching up to 1706 nm/RIU. The field analysis reveals Mie resonances as the physical reason behind the peaks. The predictive power of multiple resonant peaks from transverse magnetic and transverse electric polarizations is evaluated using Ridge Regression modeling. Systematic analysis reveals that incorporating multiple resonances yields up to 3 orders of magnitude improvement in refractive index detection precision compared to single-peak analyses. This precision enhancement is achieved without modifications to the biosensor hardware, highlighting the potential of data-centric strategies in biosensing. The findings establish a new paradigm in biosensing, demonstrating that the synergy between multiresonance data acquisition and ML-based analysis can significantly enhance detection accuracy. This study provides a scalable pathway for advancing high-precision biosensing technologies.

Indexed as

index sensorMachine learningmulti-dimensional dataMulti-resonanceridge regression

Identifiers

PMID40454011
PMCPMC12120575

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.